These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 8875445)
21. Treatment of rat hemiparkinson model with xenogeneic neural transplantation: tolerance induction by anti-T-cell antibodies. Okura Y; Tanaka R; Ono K; Yoshida S; Tanuma N; Matsumoto Y J Neurosci Res; 1997 Jun; 48(5):385-96. PubMed ID: 9185663 [TBL] [Abstract][Full Text] [Related]
22. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease. Harrower TP; Tyers P; Hooks Y; Barker RA Exp Neurol; 2006 Jan; 197(1):56-69. PubMed ID: 16246328 [TBL] [Abstract][Full Text] [Related]
30. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610 [TBL] [Abstract][Full Text] [Related]
31. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Duan WM; Widner H; Björklund A; Brundin P Neuroscience; 1993 Nov; 57(2):261-74. PubMed ID: 7906872 [TBL] [Abstract][Full Text] [Related]
32. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor. Krobert K; Lopez-Colberg I; Cunningham LA Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087 [TBL] [Abstract][Full Text] [Related]
33. Time-dependent expression of donor- and host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macro- and micrografts: comparison of two different grafting protocols. Brandis A; Kuder H; Knappe U; Jödicke A; Schönmayr R; Samii M; Walter GF; Nikkhah G Acta Neuropathol; 1998 Jan; 95(1):85-97. PubMed ID: 9452826 [TBL] [Abstract][Full Text] [Related]
34. Induction of operational tolerance to discordant dopaminergic porcine xenografts. Larsson LC; Corbascio M; Pearson TC; Larsen CP; Ekberg H; Widner H Transplantation; 2003 May; 75(9):1448-54. PubMed ID: 12792495 [TBL] [Abstract][Full Text] [Related]
35. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. Thompson L; Barraud P; Andersson E; Kirik D; Björklund A J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637 [TBL] [Abstract][Full Text] [Related]
36. Transplants in Parkinson's disease. Lindvall O Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521 [TBL] [Abstract][Full Text] [Related]
37. Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats. Duan WM; Brundin P; Grasbon-Frodl EM; Widner H Brain Res; 1996 Mar; 712(2):199-212. PubMed ID: 8814894 [TBL] [Abstract][Full Text] [Related]
38. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality. Sortwell CE; Collier TJ; Camargo MD; Pitzer MR Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588 [TBL] [Abstract][Full Text] [Related]
39. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations. Broadwell RD; Baker BJ; Ebert PS; Hickey WF Microsc Res Tech; 1994 Apr; 27(6):471-94. PubMed ID: 8012052 [TBL] [Abstract][Full Text] [Related]
40. Clinical application of neuronal grafts in Parkinson's disease. Lindvall O J Neurol; 1994 Dec; 242(1 Suppl 1):S54-6. PubMed ID: 7699411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]